Almagate

Almagate

Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	A02AD03 (WHO)
Identifiers
CAS Number	66827-12-1
PubChem (CID)	71749
ChemSpider	64792
UNII	568Z59H7ZJ
KEGG	D02821
Chemical and physical data
Formula	Al2Mg6(OH)14(CO3)2 · 4 H2O
Molar mass	314.99 g/mol
3D model (Jmol)	Interactive image
SMILES [Al+3].[Mg+2].[Mg+2].[Mg+2].[OH-].[OH-].[OH-].[O-]C([O-])=O.[OH-].[OH-].[OH-].[OH-].O.O
InChI InChI=1S/CH2O3.Al.3Mg.9H2O/c2-1(3)4;;;;;;;;;;;;;/h(H2,2,3,4);;;;;9*1H2/q;+3;3*+2;;;;;;;;;/p-9 Key:MTEOMEWVDVPTNN-UHFFFAOYSA-E
(verify)

Almagate (trade name Almax) is an aluminium- and magnesium-containing antacid. It was first described in 1984.^[1][2]

Adverse effects

Almagate is well tolerated. In a clinical trial, the most common adverse effects were diarrhea and nausea.^[3]

References

1. Moragues, J. B. (1984). "Characterization of a new crystalline synthetic gastric antacid, almagate" (Free full text). Arzneimittel-Forschung. 34 (10A): 1346–1349. ISSN 0004-4172. PMID 6548918.
2. Beneyto, J. F. B. (1984). "Evaluation of a new antacid, almagate" (Free full text). Arzneimittel-Forschung. 34 (10A): 1350–1354. ISSN 0004-4172. PMID 6439224.
3. Suau, A. D.; Dominguez Martin, A; Ferrando Cucarella, J; Juncosa Iglesias, L; Muñoz Benitez, J; Nieto Calvet, M; Pérez Gieb, J; Pérez Mota, A; Pineda Garcia, A; Rodriguez Sanchez, E (1984). "Treatment of gastric pyrosis with almagate in patients with and without endoscopically demonstrable duodenal ulcer. A multicentre clinical trial" (Free full text). Arzneimittel-Forschung. 34 (10A): 1380–1383. ISSN 0004-4172. PMID 6548926.